SABS - SAB Biotherapeutics GAAP EPS of -$7.64 misses by $3.43 revenue of $2.24M beats by $1.12M
2024-03-29 07:17:59 ET
More on SAB Biotherapeutics
- SAB Biotherapeutics announces 1-for-10 reverse stock split
- Seeking Alpha’s Quant Rating on SAB Biotherapeutics
- Historical earnings data for SAB Biotherapeutics
- Financial information for SAB Biotherapeutics